7-44188923-C-T
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2
The NM_000162.5(GCK):c.31G>A(p.Ala11Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00119 in 1,613,882 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_000162.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GCK | NM_000162.5 | c.31G>A | p.Ala11Thr | missense_variant | 1/10 | ENST00000403799.8 | |
GCK | NM_001354800.1 | c.31G>A | p.Ala11Thr | missense_variant | 1/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GCK | ENST00000403799.8 | c.31G>A | p.Ala11Thr | missense_variant | 1/10 | 1 | NM_000162.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00615 AC: 936AN: 152164Hom.: 9 Cov.: 33
GnomAD3 exomes AF: 0.00166 AC: 415AN: 250754Hom.: 3 AF XY: 0.00125 AC XY: 170AN XY: 135544
GnomAD4 exome AF: 0.000670 AC: 979AN: 1461600Hom.: 9 Cov.: 31 AF XY: 0.000553 AC XY: 402AN XY: 727062
GnomAD4 genome AF: 0.00615 AC: 937AN: 152282Hom.: 9 Cov.: 33 AF XY: 0.00565 AC XY: 421AN XY: 74450
ClinVar
Submissions by phenotype
not provided Benign:5
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 13, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 31, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 23, 2022 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 19, 2020 | This variant is associated with the following publications: (PMID: 18271687, 19228875, 8454109, 14517946, 17573900, 23506826, 19790256, 11508276, 29056535) - |
Benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Dec 30, 2016 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 17, 2013 | - - |
Maturity onset diabetes mellitus in young Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 11, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Monogenic diabetes Benign:1
Benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Aug 12, 2016 | ACMG Criteria:BP4, BS1 (3% in Africans in 1000g) , BS2(type2diabetesgenetics.org 61 cases and 49 controls, 3 homozygotes in ExAC); 6/503 TODAY, BP6 (Chicago calls benign) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at